A multicenter real-world study found that first-line trastuzumab deruxtecan doubled progression-free survival compared with ...
AstraZeneca, in collaboration with HUTCHMED, has submitted a New Drug Application to the US FDA for ORPATHYS® (savolitinib) ...
A Hong Kong model compared upfront NGS with EGFR/ALK-first testing in metastatic NSCLC, highlighting trade-offs in cost, ...
Pope Leo will undergo surgery in the coming days to remove a lung nodule that was detected during a routine checkup. The ...
Pre-screening is now underway to enroll the single patient in Cohort 2, who is expected to receive RC220 at 100 mg/m 2 with ...
Yuhan accelerates global Leclaza growth as indications widen and reimbursement lags Rising global uptake hinges on faster ...
TAHLEQUAH, Okla. The American Lung Association’s statistics on lung cancer in Oklahoma reveals those surviving the disease ...
The Evolving Economics of Upfront NGS in East Asian NSCLC / Andrea Chang, cancer, Carlos K.H. Wong, Catherine P.K. Chan, HER2 ...
EU application is back under EMA review for EGFR-mutated NSCLC. Find out what this resubmission means for patients today.
Collinsville Daily News on MSN
Targeting 'immune fog' may help stop lung cancer before it starts
There are around 125,000 lung cancer deaths in the U.S. every year.
There are around 125,000 lung cancer deaths in the U.S. every year. The post Targeting ‘immune fog’ may help stop lung before ...
From a personalized melanoma vaccine to new options for biliary, stomach, lung and endometrial cancers, here are 5 ESMO 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results